Astrana Health, Inc.

ASTH Healthcare Medical Care Facilities

Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

36.81 1.22 −3.21%
Market cap
$1.9B
P/E
44.3×
Fwd P/E
29.7×
Dividend yield
—
F-score
4/9
Altman Z
2.39
Beneish M
−2.19
Dividend safety
50/100

Astrana Health, Inc. (ASTH) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Astrana Health, Inc. (ASTH) trades at a P/E ratio of 44.3×. Over the past ten years it has ranged from 0.0× (December 2017) to 178× (October 2025); the current reading is higher than 72% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 53.9× 53.95%
FY2024 35.0× 19.25%
FY2023 29.4× 13.32%
FY2022 25.9× (40.72%)
FY2021 43.7× 151.37%
FY2020 17.4× (62.19%)
FY2019 46.0× (23.48%)
FY2018 60.2× 349.96%
FY2017 13.4× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 55.9× 41.39%
Mar 2026 39.5× (26.67%)
Dec 2025 53.9× (63.85%)
Sep 2025 149× 211.85%
34 more quarters

Against its own ten years

Low 0.0× High 178×
Ten-year median 31.4×
Current reading's percentile 69

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ASTH